MJP Similarly have been buying regularly for 7 plus years and have never sold and dont intend to. Re the value at the end of the year the Immupel technology must surely be worth more than 2 cents on its own even if Parkinson application was not succesful. So I see far less down side risk.... but the potential upside ......pick your number.!!
Hope to hear that phase 3 6 patients given go ahead imminently by Medical board and agree NZ Trader it would be timely to get an update on the original 4 trial patients and of course to hear from Carol again would be terrific . However I also would understand why she may not want herself in public domain again.
Pretty exciting this next set of 6 patients with 4 of them receiving a triple dose and to both sides of the rain. Appreciate more may not always be better but the results will be intriuging.!
- Forums
- ASX - By Stock
- 1AI
- Final, Group 3, Phase II Trials
Final, Group 3, Phase II Trials, page-3
-
- There are more pages in this discussion • 135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $1.942K | 277.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 8049466 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 303460 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 8049466 | 0.006 |
13 | 8336342 | 0.005 |
6 | 3695009 | 0.004 |
2 | 3100000 | 0.003 |
2 | 1050000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 303460 | 1 |
0.008 | 2792077 | 12 |
0.009 | 1696637 | 10 |
0.010 | 4020149 | 6 |
0.011 | 1909287 | 5 |
Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online